{"id":"https://openalex.org/W4415733698","doi":"https://doi.org/10.1177/24741264251381985","title":"Characteristics and Outcomes of Antivascular Endothelial Growth Factor Therapy in a Large Cohort of Patients With Pachychoroid Neovasculopathy","display_name":"Characteristics and Outcomes of Antivascular Endothelial Growth Factor Therapy in a Large Cohort of Patients With Pachychoroid Neovasculopathy","publication_year":2025,"publication_date":"2025-10-31","ids":{"openalex":"https://openalex.org/W4415733698","doi":"https://doi.org/10.1177/24741264251381985","pmid":"https://pubmed.ncbi.nlm.nih.gov/41180146","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12578609"},"language":"en","primary_location":{"id":"doi:10.1177/24741264251381985","doi":"https://doi.org/10.1177/24741264251381985","is_oa":true,"landing_page_url":"https://doi.org/10.1177/24741264251381985","pdf_url":null,"source":{"id":"https://openalex.org/S4210215442","display_name":"Journal of VitreoRetinal Diseases","issn_l":"2474-1264","issn":["2474-1264","2474-1272"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of VitreoRetinal Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1177/24741264251381985","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046431096","display_name":"Carolin Aizouki","orcid":"https://orcid.org/0009-0004-3168-8933","observed_orcids":["https://orcid.org/0009-0004-3168-8933"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Carolin Aizouki","raw_affiliation_strings":["University of Alberta, Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada"],"raw_orcid":"https://orcid.org/0009-0004-3168-8933","affiliations":[{"raw_affiliation_string":"University of Alberta, Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077645857","display_name":"Amit Vikram Mishra","orcid":"https://orcid.org/0009-0006-7586-0154","observed_orcids":["https://orcid.org/0009-0006-7586-0154"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Amit V. Mishra","raw_affiliation_strings":["Alberta Retina Consultants, Edmonton, Alberta, Canada","University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada"],"raw_orcid":"https://orcid.org/0009-0006-7586-0154","affiliations":[{"raw_affiliation_string":"Alberta Retina Consultants, Edmonton, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066135022","display_name":"Graeme Kenneth Loh","orcid":"https://orcid.org/0000-0001-8281-8954","observed_orcids":["https://orcid.org/0000-0001-8281-8954"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Graeme K. Loh","raw_affiliation_strings":["Alberta Retina Consultants, Edmonton, Alberta, Canada","University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada"],"raw_orcid":"https://orcid.org/0000-0001-8281-8954","affiliations":[{"raw_affiliation_string":"Alberta Retina Consultants, Edmonton, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083939877","display_name":"Nishanthan Ramachandran","orcid":"https://orcid.org/0000-0002-6919-4136","observed_orcids":["https://orcid.org/0000-0002-6919-4136"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Nishanthan Ramachandran","raw_affiliation_strings":["Alberta Retina Consultants, Edmonton, Alberta, Canada","University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alberta Retina Consultants, Edmonton, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050992975","display_name":"Mark D.J. Greve","orcid":"https://orcid.org/0000-0002-6995-4860","observed_orcids":["https://orcid.org/0000-0002-6995-4860"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mark D.J. Greve","raw_affiliation_strings":["Alberta Retina Consultants, Edmonton, Alberta, Canada","University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alberta Retina Consultants, Edmonton, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047250266","display_name":"David S. Ehmann","orcid":"https://orcid.org/0000-0003-0205-5868","observed_orcids":["https://orcid.org/0000-0003-0205-5868"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"David Ehmann","raw_affiliation_strings":["Alberta Retina Consultants, Edmonton, Alberta, Canada","University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alberta Retina Consultants, Edmonton, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043342985","display_name":"Parampal S. Grewal","orcid":"https://orcid.org/0000-0003-1525-150X","observed_orcids":["https://orcid.org/0000-0003-1525-150X"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Parampal S. Grewal","raw_affiliation_strings":["Alberta Retina Consultants, Edmonton, Alberta, Canada","University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alberta Retina Consultants, Edmonton, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030202063","display_name":"Mark E. Seamone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Mark E. Seamone","raw_affiliation_strings":["Alberta Retina Consultants, Edmonton, Alberta, Canada","University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alberta Retina Consultants, Edmonton, Alberta, Canada","institution_ids":[]},{"raw_affiliation_string":"University of Alberta, Department of Ophthalmology and Visual Sciences, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030202063"],"corresponding_institution_ids":["https://openalex.org/I154425047"],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":{"value":3900,"currency":"USD","value_usd":3900},"fwci":0.6997,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.59026062,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"10","issue":"1","first_page":"31","last_page":"37"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pachychoroid-neovasculopathy","display_name":"pachychoroid neovasculopathy","score":0.996999979019165},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.8759999871253967},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.8600000143051147},{"id":"https://openalex.org/keywords/choroidal-thickness","display_name":"choroidal thickness","score":0.7879999876022339},{"id":"https://openalex.org/keywords/central-subfield-thickness","display_name":"central subfield thickness","score":0.9229999780654907},{"id":"https://openalex.org/keywords/treat-and-extend-regimen","display_name":"treat-and-extend regimen","score":0.7850000262260437},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5789999961853027},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.6200000047683716},{"id":"https://openalex.org/keywords/photodynamic-therapy","display_name":"photodynamic therapy","score":0.9430000185966492},{"id":"https://openalex.org/keywords/long-term-outcomes","display_name":"long-term outcomes","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.932699978351593},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6909000277519226},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.6200000047683716},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6017000079154968},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.45509999990463257},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3776000142097473},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.3578000068664551},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.35580000281333923},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.31839999556541443},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.3167000114917755},{"id":"https://openalex.org/C2780248432","wikidata":"https://www.wikidata.org/wiki/Q1434206","display_name":"Fluorescein angiography","level":3,"score":0.2989000082015991},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.29420000314712524},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.2906000018119812},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28349998593330383},{"id":"https://openalex.org/C2781323092","wikidata":"https://www.wikidata.org/wiki/Q1428072","display_name":"Photodynamic therapy","level":2,"score":0.271699994802475},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2702000141143799},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.26190000772476196}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1177/24741264251381985","doi":"https://doi.org/10.1177/24741264251381985","is_oa":true,"landing_page_url":"https://doi.org/10.1177/24741264251381985","pdf_url":null,"source":{"id":"https://openalex.org/S4210215442","display_name":"Journal of VitreoRetinal Diseases","issn_l":"2474-1264","issn":["2474-1264","2474-1272"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of VitreoRetinal Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12578609","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12578609/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12578609/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Vitreoretin Dis","raw_type":"Text"},{"id":"pmid:41180146","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41180146","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of vitreoretinal diseases","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/24741264251381985","doi":"https://doi.org/10.1177/24741264251381985","is_oa":true,"landing_page_url":"https://doi.org/10.1177/24741264251381985","pdf_url":null,"source":{"id":"https://openalex.org/S4210215442","display_name":"Journal of VitreoRetinal Diseases","issn_l":"2474-1264","issn":["2474-1264","2474-1272"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of VitreoRetinal Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415733698.pdf","grobid_xml":"https://content.openalex.org/works/W4415733698.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W2135099241","https://openalex.org/W2320279835","https://openalex.org/W2408303061","https://openalex.org/W2734538819","https://openalex.org/W2788224302","https://openalex.org/W2790202676","https://openalex.org/W2868988997","https://openalex.org/W2914154706","https://openalex.org/W2914603466","https://openalex.org/W2915245279","https://openalex.org/W3108664723","https://openalex.org/W3128345212","https://openalex.org/W3134921859","https://openalex.org/W3155951917","https://openalex.org/W3164452175","https://openalex.org/W3167983266","https://openalex.org/W3183583119","https://openalex.org/W3207550861","https://openalex.org/W4211027220","https://openalex.org/W4280530534","https://openalex.org/W4361301426","https://openalex.org/W4367627471"],"related_works":["https://openalex.org/W2915245279","https://openalex.org/W4280530534","https://openalex.org/W3167983266","https://openalex.org/W4413220098","https://openalex.org/W3014212504","https://openalex.org/W3164452175","https://openalex.org/W4391420481","https://openalex.org/W3134921859","https://openalex.org/W2788224302","https://openalex.org/W2975460836"],"abstract_inverted_index":{"Purpose:":[0],"To":[1],"examine":[2],"the":[3,95,220],"long-term":[4],"visual":[5,76],"and":[6,60,114,199],"morphologic":[7],"outcomes":[8],"in":[9,37,129,144,161,166,184,202,215],"a":[10,134,167,177],"large":[11,204],"series":[12],"of":[13,32,40,85,148,171,180,206],"patients":[14,42,185,207],"with":[15,19,43,82,133,176,208],"pachychoroid":[16,44,209],"neovasculopathy":[17,45],"treated":[18],"intravitreal":[20],"antivascular":[21],"endothelial":[22],"growth":[23],"factor":[24],"(anti-VEGF)":[25],"injections.":[26],"Methods:":[27],"A":[28],"retrospective,":[29],"observational":[30],"study":[31,96,221],"anti-VEGF":[33,188],"injections":[34],"was":[35,57,63,79,127,142,159,213],"performed":[36],"249":[38],"eyes":[39,131,146,151,163,217],"237":[41],"at":[46,219],"1":[47],"retina":[48],"center":[49],"over":[50],"7":[51],"years.":[52],"Results:":[53],"Mean":[54],"patient":[55],"age":[56],"65.5":[58],"years":[59,65],"mean":[61,74,106,115,168,178],"follow-up":[62],"1.91":[64],"(range,":[66],"3":[67],"months":[68],"to":[69,104],"7.14":[70],"years).":[71],"At":[72],"baseline,":[73],"best-corrected":[75],"acuity":[77],"(BCVA)":[78],"20/60":[80],"Snellen,":[81],"an":[83],"improvement":[84,170,179],"2.30":[86,181],"Early":[87],"Treatment":[88,140],"Diabetic":[89],"Retinopathy":[90],"Study":[91],"(ETDRS)":[92],"letters":[93,183],"by":[94,111,119],"endpoint":[97],"(":[98,190],"P":[99,123,191],"=":[100,192],".04).":[101],"From":[102],"baseline":[103],"endpoint,":[105],"central":[107],"subfield":[108],"thickness":[109,117],"decreased":[110,118],"78.2":[112],"\u03bcm,":[113],"choroidal":[116],"35.4":[120],"\u03bcm":[121],"(each":[122],"<":[124],".05).":[125],"Treat-and-extend":[126],"utilized":[128,160],"192":[130],"(77.9%),":[132],"42.3%":[135],"recurrence":[136],"rate":[137],"on":[138],"extension.":[139],"cessation":[141],"trialed":[143],"70":[145],"(28.1%),":[147],"which":[149],"53":[150],"required":[152,214],"no":[153],"further":[154],"treatment.":[155],"Adjunct":[156],"photodynamic":[157],"therapy":[158,196],"34":[162],"(13.7%),":[164],"resulting":[165],"vision":[169],"0.44":[172],"ETDRS":[173,182],"letters,":[174],"compared":[175],"who":[186],"received":[187],"only":[189],".6).":[193],"Conclusions:":[194],"Anti-VEGF":[195],"improved":[197],"BCVA":[198],"anatomic":[200],"features":[201],"this":[203],"cohort":[205],"neovasculopathy.":[210],"Continued":[211],"treatment":[212],"196":[216],"(78.7%)":[218],"endpoint.":[222]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2025-10-31T00:00:00"}